Dr. Dulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6565 Arlington Blvd
Ste 200
Falls Church, VA 22042Phone+1 703-531-3627Fax+1 703-531-1590
Summary
- Robin (Yates) Dulman, MD is a healthcare professional specializing in Pediatric Hematology & Oncology, located in Fairfax, VA. She completed both her fellowship and residency in related fields at NYU Grossman School of Medicine after graduating from Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in 2001. Dr. Dulman has an impressive publication history in reputable journals such as Haematologica, Pediatric Blood & Cancer, European Journal of Haematology, and Pediatric Hematology and Oncology. She is also involved in clinical trials exploring the effectiveness of the Neutropenic Diet in pediatric oncology patients.
Education & Training
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008- NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2001
Certifications & Licensure
VA State Medical License 2010 - 2026
NY State Medical License 2003 - 2012
CT State Medical License 2004 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients Start of enrollment: 2007 Sep 01
Publications & Presentations
PubMed
- 42 citationsA randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patientsKaren Moody, Rebecca Baker, Ruth Santizo, Inan Olmez, Jeanie Marie Spies
Pediatric Blood & Cancer. 2018-01-01 - 8 citationsWild type N-ras displays anti-malignant properties, in part by downregulating decorinMarta Benet, Robin Yates Dulman, Raffi Suzme, Eleazar Vega-Saenz de Miera, Martha E. Vega
Journal of Cellular Physiology. 2012-06-01 - 12 citationsProspective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancy.Ronay Thomas, Robin Dulman, Angela Lewis, Bailey Notarangelo, Elizabeth Yang
Pediatric Blood & Cancer. 2019-09-01
Press Mentions
- Kate’s Cause Supports Alex’s Lemonade Stand Foundation’s Crazy 8 InitiativeMay 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
